• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金刚烷胺与苯海索治疗抗精神病药所致帕金森综合征的对比研究

Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.

作者信息

Fann W E, Lake C R

出版信息

Am J Psychiatry. 1976 Aug;133(8):940-3. doi: 10.1176/ajp.133.8.940.

DOI:10.1176/ajp.133.8.940
PMID:782262
Abstract

Amantadine is a putative dopaminergic compound known to be therapeutically effective in idiopathic and postencephalitic Parkinson's disease. In a double-blind placebo-controlled crossover study of 39 psychiatric inpatients, amantadine and trihexyphenidyl were equally effective in treating drug-induced parkinsonism, and amantadine produced fewer and less severe side effects. The authors suggest that amantadine is an effective alternative to atropine-like agents, with fewer implications for long-term risk of tardive dyskinesia.

摘要

金刚烷胺是一种公认的多巴胺能化合物,已知对特发性和脑炎后帕金森病具有治疗效果。在一项针对39名精神科住院患者的双盲安慰剂对照交叉研究中,金刚烷胺和苯海索在治疗药物性帕金森综合征方面同样有效,且金刚烷胺产生的副作用更少、程度更轻。作者认为,金刚烷胺是阿托品样药物的有效替代品,对迟发性运动障碍的长期风险影响较小。

相似文献

1
Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism.金刚烷胺与苯海索治疗抗精神病药所致帕金森综合征的对比研究
Am J Psychiatry. 1976 Aug;133(8):940-3. doi: 10.1176/ajp.133.8.940.
2
No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.比哌立登与金刚烷胺对帕金森氏症和迟发性运动障碍型不自主运动的疗效无差异:一项针对药物治疗的慢性精神分裂症患者的双盲交叉、安慰剂对照研究。
J Clin Psychiatry. 1995 Apr;56(4):167-70.
3
Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms.多巴胺能与抗胆碱能药物治疗药物性锥体外系症状的记忆功能差异
Am J Psychiatry. 1988 Apr;145(4):483-6. doi: 10.1176/ajp.145.4.483.
4
Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect.金刚烷胺对药物性帕金森综合征的作用:血浆水平与疗效的关系。
Br J Clin Pharmacol. 1976 Oct;3(5):883-9. doi: 10.1111/j.1365-2125.1976.tb00642.x.
5
A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms.EX 10-029与盐酸苯海索缓解药物性帕金森症状疗效的双盲比较。
Curr Ther Res Clin Exp. 1972 Aug;14(8):470-7.
6
Effects of anticholinergic agents on patients with tardive dyskinesia and concomitant drug-induced parkinsonism.抗胆碱能药物对迟发性运动障碍及伴发药物性帕金森综合征患者的影响。
J Clin Psychopharmacol. 1989 Dec;9(6):407-11.
7
Revisiting amantadine as a treatment for drug-induced movement disorders.重新审视金刚烷胺作为药物性运动障碍的一种治疗方法。
Ann Clin Psychiatry. 2020 Aug;32(3):198-208.
8
Amantadine in Parkinson's disease. A double-blind, placebo-controlled, crossover study with long-term follow-up.金刚烷胺治疗帕金森病。一项双盲、安慰剂对照、交叉试验及长期随访研究。
Neurology. 1975 Jul;25(7):603-6. doi: 10.1212/wnl.25.7.603.
9
The antiparkinson properties of amantadine in drug-induced parkinsonism.
J Clin Pharmacol New Drugs. 1971 May-Jun;11(3):211-4.
10
The effect of amantadine on neuroleptic-induced parkinsonism.金刚烷胺对抗精神病药物所致帕金森综合征的作用。
Act Nerv Super (Praha). 1973 May;15(2):93.

引用本文的文献

1
Updated Perspectives on the Management of Drug-Induced Parkinsonism (DIP): Insights from the Clinic.药物性帕金森综合征(DIP)管理的最新观点:来自临床的见解
Ther Clin Risk Manag. 2022 Dec 20;18:1129-1142. doi: 10.2147/TCRM.S360268. eCollection 2022.
2
Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative Review.老年患者抗精神病药物所致帕金森综合征的识别与管理:一项叙述性综述
Medicines (Basel). 2021 May 26;8(6):24. doi: 10.3390/medicines8060024.
3
Overcoming barriers to effective management of tardive dyskinesia.
克服迟发性运动障碍有效管理的障碍。
Neuropsychiatr Dis Treat. 2019 Apr 4;15:785-794. doi: 10.2147/NDT.S196541. eCollection 2019.
4
[Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 1 : Dystonia, akathisia und parkinsonism].[精神分裂症性精神病中抗精神病药物所致运动症状——第1部分:肌张力障碍、静坐不能和帕金森综合征]
Nervenarzt. 2019 Jan;90(1):1-11. doi: 10.1007/s00115-018-0582-5.
5
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.抗精神病药物相关运动障碍:药物性帕金森综合征与迟发性运动障碍——病理生理学和临床管理的关键差异
Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19.
6
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.用于抗精神病药物所致迟发性运动障碍的非抗精神病类儿茶酚胺能药物。
Cochrane Database Syst Rev. 2018 Jan 18;1(1):CD000458. doi: 10.1002/14651858.CD000458.pub3.
7
Anticholinergic medication for antipsychotic-induced tardive dyskinesia.用于抗精神病药物所致迟发性运动障碍的抗胆碱能药物。
Cochrane Database Syst Rev. 2018 Jan 17;1(1):CD000204. doi: 10.1002/14651858.CD000204.pub2.
8
Neurologic Complications of Commonly Used Drugs in the Hospital Setting.医院环境中常用药物的神经并发症。
Curr Neurol Neurosci Rep. 2016 Apr;16(4):35. doi: 10.1007/s11910-016-0636-7.
9
Neuroleptic-induced Parkinsonism: Clinicopathological study.抗精神病药物所致帕金森综合征:临床病理研究。
Mov Disord. 2016 Mar;31(3):360-5. doi: 10.1002/mds.26467. Epub 2015 Dec 11.
10
[Not Available].[无可用内容]
Paediatr Child Health. 2012 Oct;17(Suppl B):22B-30B.